A recent investigation suggests PAI-1 is directly involved in the development of diet-induced hyperlipidemia and hepatic steatosis through regulation of PCSK9 (proprotein convertase subtilisin/kexin type 9), an important regulator of lipid metabolism in the liver [42]. The gene discussed is PCSK9; the disease is Hepatic steatosis.